Blackstone’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Other funds holding KRYS
Blackstone's KRYS Position: Q2 2026 in Review
Blackstone sold out of Krystal Biotech (KRYS) in Q2 2026, closing a stake of 2,246 shares — an estimated $580K sold.
Blackstone first reported a position in KRYS in Q1 2026 and held it in 1 quarter. The position peaked at $580K in Q1 2026. 426 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.
- Blackstone reported no remaining Krystal Biotech position as of Q2 2026 after selling out during the quarter.
- Blackstone sold 2,246 Krystal Biotech shares in Q2 2026, an estimated $580K.
- Blackstone first reported a position in Krystal Biotech in Q1 2026 and held it in 1 quarter.
- Blackstone's Krystal Biotech position peaked at $580K in Q1 2026.
- 426 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.
Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.